IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
Public ClinicalTrials.gov record NCT00091507. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to test the impact of pharmacological myocardial metabolic support, in the form of intravenous (IV) glucose, insulin and potassium (GIK), for the treatment of patients with threatened or established acute myocardial infarction (AMI).
Study identification
- NCT ID
- NCT00091507
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 911 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2006 (Type not available)
- Primary completion
- Aug 2011 (Actual)
- Completion
- Aug 2012 (Actual)
- Last update posted
- Mar 2, 2016
2006 – 2012
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anchorage Site | Anchorage | Alaska | 99501 | — |
| New Haven Site | New Haven | Connecticut | 06511 | — |
| Macon Site | Macon | Georgia | 31208 | — |
| Brockton Site | Brockton | Massachusetts | 02301 | — |
| Concord Site | Concord | Massachusetts | 01742 | — |
| St. Paul Site | Saint Paul | Minnesota | 55128 | — |
| Albuquerque Site | Albuquerque | New Mexico | 87131 | — |
| Hershey Site | Hershey | Pennsylvania | 17033 | — |
| Sioux Falls Site | Sioux Falls | South Dakota | 57104 | — |
| Dallas Site | Dallas | Texas | 75201 | — |
| El Paso Site | El Paso | Texas | 79905 | — |
| Bellingham Site | Bellingham | Washington | 98225 | — |
| Milwaukee Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00091507, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2016 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00091507 live on ClinicalTrials.gov.